Spinal muscular atrophy (SMA) is a severe neuromuscular disorder due to a defect in the survival motor neuron 1 (SMN1) gene. Its incidence is approximately 1 in 11,000 live births. In 2007, an International Conference on the Standard of Care for SMA published a consensus statement on SMA standard of care that has been widely used throughout the world. Here we report a two-part update of the topics covered in the previous recommendations. In part 1 we present the methods used to achieve these recommendations, and an update on diagnosis, rehabilitation, orthopedic and spinal management; and nutritional, swallowing and gastrointestinal management. Pulmonary management, acute care, other organ involvement, ethical issues, medications, and the impact of new treatments for SMA are discussed in part 2.

Diagnosis and management of spinal muscular atrophy : Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care / E. Mercuri, R.S. Finkel, F. Muntoni, B. Wirth, J. Montes, M. Main, E.S. Mazzone, M. Vitale, B. Snyder, S. Quijano-Roy, E. Bertini, R.H. Davis, O.H. Meyer, A.K. Simonds, M.K. Schroth, R.J. Graham, J. Kirschner, S.T. Iannaccone, T.O. Crawford, S. Woods, Y. Qian, T. Sejersen, F.D. Tiziano, E. Tizzano, H. Topaloglu, K. Swoboda, N. Laing, S. Kayoko, T. Prior, W.K. Chung, S.-. Wu, C. Coleman, R. Gee, A. Glanzman, A.-. Kroksmark, K. Krosschell, L. Nelson, K. Rose, A. Stepien, C. Vuillerot, J. Dubousset, D. Farrington, J. Flynn, M. Halanski, C. Hasler, L. Miladi, C. Reilly, B. Roye, M. Yazici, R. Hurst, S. Tarrant, S. Bertoli, K. Foust, B. Kyle, L. Rodan, H. Roper, E. Seffrood, A. Szlagatys-Sidorkiewicz. - In: NEUROMUSCULAR DISORDERS. - ISSN 0960-8966. - 28:2(2018), pp. 103-115. [10.1016/j.nmd.2017.11.005]

Diagnosis and management of spinal muscular atrophy : Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care

S. Bertoli
Membro del Collaboration Group
;
2018

Abstract

Spinal muscular atrophy (SMA) is a severe neuromuscular disorder due to a defect in the survival motor neuron 1 (SMN1) gene. Its incidence is approximately 1 in 11,000 live births. In 2007, an International Conference on the Standard of Care for SMA published a consensus statement on SMA standard of care that has been widely used throughout the world. Here we report a two-part update of the topics covered in the previous recommendations. In part 1 we present the methods used to achieve these recommendations, and an update on diagnosis, rehabilitation, orthopedic and spinal management; and nutritional, swallowing and gastrointestinal management. Pulmonary management, acute care, other organ involvement, ethical issues, medications, and the impact of new treatments for SMA are discussed in part 2.
Care; Diagnosis; Nutrition; Orthopedic; Phisotherapy; Spinal muscular atrophy; Disease Management; Humans; Spinal Muscular Atrophies of Childhood
Settore MED/49 - Scienze Tecniche Dietetiche Applicate
2018
Article (author)
File in questo prodotto:
File Dimensione Formato  
main.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 1.02 MB
Formato Adobe PDF
1.02 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/702816
Citazioni
  • ???jsp.display-item.citation.pmc??? 245
  • Scopus 580
  • ???jsp.display-item.citation.isi??? 485
social impact